Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06491238 MG-Ex — Light vs. Moderate Intensity Exercise in Individuals With Myast… |
MG-Ex — Light vs. Moderate Intens… | Myasthénie | Non applicable | RECRUITING | En attente / non publié | HealthPartners Institute | United States · HealthPartners Neuroscience Center, S… | 2024-09-16 → 2026-12 | Ouvrir |
| NCT06607627 PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients… |
Gefurulimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Brazil, Japan, Poland, Taiwan · Resear… | 2024-11-13 → 2029-01-23 | Ouvrir |
| NCT07512375 MY-EDUC — The Effectiveness of an ETP Programme in Myasthenia Gravis: a… |
MY-EDUC — The Effectiveness of an… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Grenoble | Non communiqué | 2026-04 → 2027-06 | Ouvrir |
| NCT07499323 Talquetamab in Patients With Refractory Generalized Myasthenia Gravis |
Talquetamab | Myasthénie | Non applicable | NOT_YET_RECRUITING | En attente / non publié | First Affiliated Hospital of Chon… | Non communiqué | 2026-03-20 → 2027-04-01 | Ouvrir |
| NCT07249632 A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG) |
Telitacicept | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | The Children's Hospital of Zhejia… | China · Beijing Hospital, Beijing, China | 2026-01-13 → 2027-02-28 | Ouvrir |
| NCT06754020 TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis … |
Heart Rate Variability,HRV - ANSW… | Myasthénie | Non applicable | RECRUITING | En attente / non publié | Yi Ting Yeh | Taiwan · Yi Ting Yeh, New Taipei City, Taiwan | 2023-01-17 → 2027-12-31 | Ouvrir |
| NCT06312644 Study of Ultomiris® (Ravulizumab) Safety in Pregnancy |
Ultomiris | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Australia, France, Germany, Italy, Sou… | 2024-12-16 → 2034-07-11 | Ouvrir |
| NCT07532707 Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria. |
IVIG (Intravenous Immunoglobulin) | Myasthénie | Non applicable | COMPLETED | En attente / non publié | Damascus University | Syria · Damascus University, Damascus, Syria | 2022-09-01 → 2023-10-30 | Ouvrir |
| NCT05644561 Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravuli… |
Ravulizumab | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Italy, Japan, Serbia, Switzerland · Re… | 2023-06-24 → 2028-06-30 | Ouvrir |
| NCT05332210 Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patien… |
HBM9161 Injection (680mg) | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | Harbour BioMed (Guangzhou) Co. Lt… | China · Huashan Hospital, Fudan University, Shanghai,… | 2022-06-30 → 2024-04-26 | Ouvrir |
| NCT06220201 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels… |
CC-97540 | Myasthénie | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Juno Therapeutics, Inc., a Bristo… | United States, Belgium, France, Germany, Spain, Unite… | 2024-03-28 → 2027-07-15 | Ouvrir |
| NCT05374590 ADAPT Jr + — Evaluating Long-term Safety of Efgartigimod Administered I… |
Efgartigimod IV or Efgartigimod P… | Myasthénie | Phase 2/3 | ENROLLING_BY_INVITATION | En attente / non publié | argenx | United States, Belgium, Canada, France, Germany, Isra… | 2022-08-18 → 2029-09 | Ouvrir |
| NCT04377217 CV4DIAGNOSIS — Computerized Facial Recognition for Automated Diagnosis … |
CV4DIAGNOSIS — Computerized Facia… | Myopathies | Non applicable | COMPLETED | En attente / non publié | Centre Hospitalier Universitaire … | France · Hopital Pasteur 2, Nice, France | 2019-03-05 → 2026-02-04 | Ouvrir |
| NCT07608432 Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251)… |
Zeleciment Rostudirsen (DYNE-251) | Myopathies | Phase 3 | RECRUITING | En attente / non publié | Dyne Therapeutics | United States · Rare Disease Research, LLC, Hillsboro… | 2026-06 → 2032-10 | Ouvrir |
| NCT07304154 A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refr… |
KITE-363 | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | Kite, A Gilead Company | United States, Australia, Canada · Columbia Universit… | 2026-04-10 → 2029-06 | Ouvrir |
| NCT07609394 Duchenne Electronic Health Record Study |
Duchenne Electronic Health Record… | Myopathies | À vérifier | RECRUITING | En attente / non publié | The Duchenne Registry | United States · Arkansas Children's Hospital, Little … | 2022-12-01 → 2072-12 | Ouvrir |
| NCT06861270 CouDuMyo — Estimation of Non-Reimbursable Costs for Patients With Duche… |
CouDuMyo — Estimation of Non-Reim… | Myopathies | À vérifier | COMPLETED | En attente / non publié | Assistance Publique - Hôpitaux de… | France · AP-HP Hôtel Dieu, Paris, France | 2024-03-28 → 2025-07-31 | Ouvrir |
| NCT06844214 BrAAVe — A Study to Investigate the Safety, Tolerability, and Efficacy … |
SAR446268 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Sanofi | United States, Argentina, Australia, Canada, Israel, … | 2025-07-23 → 2032-04-27 | Ouvrir |
| NCT00912041 BrainGate2: Feasibility Study of an Intracortical Neural Interface Syst… |
Placement of the BrainGate2 senso… | Myopathies | Non applicable | RECRUITING | En attente / non publié | Leigh R. Hochberg, MD, PhD. | United States · Baylor College of Medicine, Houston, … | 2009-05 → 2038-12 | Ouvrir |
| NCT06101940 Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy… |
Skeletal muscle biopsy (residual … | Myopathies | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | Huashan Hospital | China · Chifeng Municipal Hospital, Chifeng, China | … | 2021-08-01 → 2035-12-30 | Ouvrir |
| NCT01568658 Genetic and Physical Study of Childhood Nerve and Muscle Disorders |
Genetic and Physical Study of Chi… | Myopathies | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2012-03-20 | Ouvrir |
| NCT07629284 Home-Based Tele-Rehabilitation for Respiratory Function in Children Wit… |
Home-Based Tele-Rehabilitation fo… | Myopathies | Non applicable | ENROLLING_BY_INVITATION | En attente / non publié | Samsung Medical Center | South Korea · Samsung Medical Center, Seoul, South Ko… | 2026-01-23 → 2027-03-31 | Ouvrir |
| NCT07630389 REACH-DM KIDS — Remote Assessments and Genetic Determinants of Congenit… |
REACH-DM KIDS — Remote Assessment… | Myopathies | À vérifier | RECRUITING | En attente / non publié | University of Rochester | United States · University of Rochester, Rochester, U… | 2023-11-13 → 2030-01-01 | Ouvrir |
| NCT07423026 TODDLER — A Remote Study Using Technology to Assess Outcomes in DMD |
TODDLER — A Remote Study Using Te… | Myopathies | À vérifier | RECRUITING | En attente / non publié | University of Oxford | United Kingdom · Oxford University, Oxford, United Ki… | 2026-06-24 → 2028-07-01 | Ouvrir |
| NCT03981575 Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (E… |
Estab Biomarkers and Clinical End… | Myopathies | À vérifier | RECRUITING | En attente / non publié | Virginia Commonwealth University | United States, Canada, Germany, Italy, Netherlands, N… | 2019-01-01 → 2026-12-01 | Ouvrir |